Tag Archives: Alkermes

Thinking Boldly: Alkermes Acquires Rodin Therapeutics
November 18, 2019

Today Alkermes announced its acquisition of Rodin Therapeutics, a leader in the field of synaptic dysfunction and neuronal epigenetics. Alkermes extensive experience in CNS diseases made them an ideal partner for Rodin, and this acquisition helps expand Alkermes’ efforts into

Leave a comment